Cargando…

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses

The genetic diversity of HIV impedes vaccine development. Identifying the viral properties of transmitted/founder (T/F) variants may provide a common vaccine target. To study the biological nature of T/F viruses, we constructed full-length clones from women detected during Fiebig stage I acute HIV-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luthuli, Bonisile, Gounder, Kamini, Deymier, Martin J., Dong, Krista L., Balazs, Alejandro B., Mann, Jaclyn K., Ndung'u, Thumbi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208420/ https://www.ncbi.nlm.nih.gov/pubmed/37084644 http://dx.doi.org/10.1016/j.virol.2023.04.001

Ejemplares similares

Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma
por: Jeewanraj, Neschika, et al.
Publicado: (2023)

Corrigendum to “Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma” [Virology 582 (2023) 62–70]
por: Jeewanraj, Neschika, et al.
Publicado: (2023)

Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes
por: Madlala, Paradise, et al.
Publicado: (2023)

Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa
por: Farinre, Omotayo, et al.
Publicado: (2021)

Genetic determinants of Nef-mediated CD4 and HLA class I down-regulation differences between HIV-1 subtypes B and C
por: Mann, Jaclyn K., et al.
Publicado: (2015)

HIV-1 vaccine immunogen design strategies
por: Mann, Jaclyn K, et al.
Publicado: (2015)

The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19
por: Mann, Jaclyn Kelly, et al.
Publicado: (2020)

High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection
por: Gounder, Kamini, et al.
Publicado: (2015)

HIV-1 DNA sequence diversity and evolution during acute subtype C infection
por: Lee, Guinevere Q., et al.
Publicado: (2019)

Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection
por: Mandizvo, Tawanda, et al.
Publicado: (2022)

Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency
por: Sutherland, Katherine A., et al.
Publicado: (2016)

The KT Jeang retrovirology prize 2023: Thumbi Ndung’u
por: Ndung’u, Thumbi
Publicado: (2023)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
por: Naicker, Delon, et al.
Publicado: (2023)

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles
por: Moyano, Ana, et al.
Publicado: (2023)

Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0–5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa
por: Famoroti, Temitayo, et al.
Publicado: (2018)

HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses
por: Lumngwena, Evelyn Ngwa, et al.
Publicado: (2020)

The Fitness Landscape of HIV-1 Gag: Advanced Modeling Approaches and Validation of Model Predictions by In Vitro Testing
por: Mann, Jaclyn K., et al.
Publicado: (2014)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
por: Archary, Derseree, et al.
Publicado: (2010)

Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection
por: Naidoo, Kewreshini K., et al.
Publicado: (2021)

COVID-19 in Africa: preexisting immunity and HIV
por: Snyman, Jumari, et al.
Publicado: (2021)

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals
por: Ngcapu, Sinaye, et al.
Publicado: (2017)

A20 Deep sequencing reveals viral evolution in GAG within protective HLA Alleles B*57: 02, B*58: 01, and B*7 supertype individuals acutely infected with HIV-1 subtype C in Durban, South Africa
por: Gounder, K, et al.
Publicado: (2018)

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay
por: Fernandez, Natalia, et al.
Publicado: (2022)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
por: O’Brien, Sean P., et al.
Publicado: (2019)

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
por: Stoddard, Mark B., et al.
Publicado: (2015)

Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5
por: Jin, Steven W., et al.
Publicado: (2020)

Bringing social context into global biomedical HIV cure-related research: An urgent call to action
por: Miall, Annie, et al.
Publicado: (2021)

Modelling and in vitro testing of the HIV-1 Nef fitness landscape
por: Barton, John P, et al.
Publicado: (2019)

Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences
por: Song, Hongshuo, et al.
Publicado: (2016)

High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses
por: Dutta, Debashis, et al.
Publicado: (2018)

Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients
por: Mlimi, Hlelolwenkosi, et al.
Publicado: (2022)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

Genetic Characteristics, Coreceptor Usage Potential and Evolution of Nigerian HIV-1 Subtype G and CRF02_AG Isolates
por: Ajoge, Hannah O., et al.
Publicado: (2011)

Generation of diverse neuronal subtypes in cloned populations of stem-like cells
por: Varga, Balázs V, et al.
Publicado: (2008)

CD8 lymphocytes mitigate HIV-1 persistence in lymph node follicular helper T cells during hyperacute-treated infection
por: Baiyegunhi, Omolara O., et al.
Publicado: (2022)

Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants
por: Ogunshola, Funsho, et al.
Publicado: (2018)

Development of infectious cDNA clones of Salmonid alphavirus subtype 3
por: Karlsen, Marius, et al.
Publicado: (2010)

Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection
por: Jennewein, Madeleine F., et al.
Publicado: (2020)

Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site M(Hgb) and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South Africa
por: Jaggernath, Manjeetha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_emt8hb5ppfja1ugbnc2upf7len